More frequent in-person social interaction is linked with a significantly lower risk of symptoms of major depression and posttraumatic stress disorder (PTSD) in US military veterans, according to a study published online.


ORLANDO, Fla.—Infusion with the investigational compound brexanolone outperformed selective serotonin reuptake inhibitors (SSRIs) for the treatment of postpartum depression, according to a study presented at Psych Congress 2018.

ORLANDO, Fla.—Mark Zimmerman, MD, addressed a pair of controversies in depression treatment at Psych Congress 2018: Are antidepressants only effective in patients with severe depression, and, in this population, does evidence suggest psychotherapy has little or no place in care?

ORLANDO, Fla.—The opening session of the 31st annual Psych Congress gave attendees a detailed view of the ways in which psychedelic compounds such as psilocybin and LSD affect the brain and how they could be used in psychiatric practice.

ORLANDO, Fla.—Two descriptions of depression presented at the Psych Congress 2018 preconference appeared to have little in common. But they were actually the same tale, told from vastly different points of view.

New guidelines from the European Psychiatric Association promote exercise as a core part of treatment for severe mental illnesses, including major depressive disorder and schizophrenia.



Word on the street is that many physicians do not like undergoing split treatment when they become the patient.

We perpetuate the feeling of being not good enough through slights and microaggressions that we unconsciously inflict upon our peers and colleagues.

Given the high rates of burnout in doctors in this country—and recent research that shows the rates are actually increasing—a telephone call from a colleague in distress is not uncommon.



Roger McIntyre, MD, FRCPC; Dao Thai-Cuarto, PharmD; Joshua Burke, MS; Scott Siegert, PharmD; Dimitri Grigoriadis, PhD
Joseph McEvoy, MD; Benjamin Carroll, PharmD; Sanjay Gandhi, PhD; Avery Rizio, PhD; Stephen Maher, PhD; Mark Kosinski, MA; Jakob Bjorner, MD, PhD
Sanjida Ali, BSc, MBA; Pamela Landsman-Blumberg, MPH DrPH; Marla Kugel, MPH BS; Kenneth Kramer, PhD; Kelly Krogh, PhD
Stewart Factor, DO; Karen Anderson, MD; Mat Davis, PhD; Robert Hauser, MD, MBA; Lars Jarskog, MD; Joohi Jimenez-Shahed, MD; Rajeev Kumar, MD, FRCPC; Stanislaw Ochudlo, MD, PhD; William Ondo, MD; Hubert Fernandez, MD



Psych Congress Steering Committee members Vladimir Maletic, MD, MS, and Jon W. Draud, MD, MS, discuss the clinical consequences of misdiagnosing mixed mood states.

Psych Congress Steering Committee members Vladimir Maletic, MD, MS, and Jon W. Draud, MD, MS, discuss established and emerging treatment options for patients with mixed mood states.

Dr. Murrough discusses new research regarding a novel approach for depression management.